















httpDiseases of the thoracic aorta in women
Tam T. T. Huynh, MD,a and Jean E. Starr, MD, FACS,b Houston, Tex; and Columbus, Ohio
Women have now equaled or surpassed men in the number of cardiovascular deaths per year in published statistics. In
2006, according to the National Center for Health Statistics and the Center for Disease Control, cardiovascular disease
was the cause of death in 428,906 women (35% of all deaths in women) and in 394,840 men (33% of all deaths in men).
Of those numbers, it was estimated that 5506 women (0.4% of all deaths in women) and 7732 men (0.6%) died because of
aortic aneurysm or dissection. Currently, aortic disease ranks as the 19th leading cause of death with reported increases in
incidence. Historically, aortic disease is thought to affect men more frequently than women with a varying reported
gender ratio. Gender bias has long been implicated as an important factor, but often overlooked, in the analysis and
interpretation of cardiovascular diseases outcome, in part, because of the under-representation of women in clinical trials
and studies. In this section, we provide an up-to-date review of the epidemiology and management of common diseases of
the thoracic aorta, focusing on the differences and similarities in women and men. (J Vasc Surg 2013;57:11S-7S.)Cardiovascular disease remains the number one cause of
death in the United States.1 Although the mortality rates
attributable to cardiovascular disease have declined since
the 1980s, women have now equaled or surpassed men in
the number of cardiovascular deaths per year in published
statistics. In 2006, according to the National Center for
Health Statistics and Center for Disease Control, cardiovas-
cular disease was the cause of death in 428,906 women (35%
of all deaths in women) and in 394,840 men (33% of all
deaths in men).2 Of those numbers, it was estimated that
5506 women (0.4% of all deaths in women) and 7732 men
(0.6%) died from an aortic aneurysmor dissection.Currently,
aortic disease ranks as the 19th leading cause of death with
reported increases in incidence. Historically, aortic disease
is thought to affect men more frequently than women with
varying reported gender ratio. Gender bias has long been
implicated as an important factor, but often overlooked, in
the analysis and interpretation of cardiovascular diseases
(and health) outcome, in part, because of the under-
representation of women in clinical trials and studies.3 In
this section, we provide an up-to-date review of the epidemi-
ology and management of common diseases of the thoracic
aorta, focusing on the differences and similarities in women
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Medialwall degeneration (formerlyknownas cysticmedial
necrosis) is thought to be the underlying histopathologic
abnormality causing the development of thoracic aortic aneu-
rysms (TAAs; ascending, arch, and descending). The charac-
teristics of medial degeneration are loss of smooth muscle
cells, fragmented and diminished number of elastic ﬁbers,
and increased accumulation of proteoglycans, a triad that
used to be known as cystic medial necrosis. In contrast, the
formation of infrarenal abdominal aortic aneurysms (AAAs)
is more commonly associated with atherosclerosis and an inﬁl-
tration of inﬂammatory cells into the media and adventitia,
although the underlyingmechanism remains to be elucidated.
To date, there are no studies to suggest gender differences in
the histopathology of aortic aneurysms. However, the gender
distribution is signiﬁcantly different with a higher ratio of men
to women for AAAs 2 to 5: 1, compared with approximately
1.7: 1 for TAAs.4-7 The explanation for this gender differenti-
ation remains to be elucidated.EPIDEMIOLOGY AND NATURAL HISTORY OF
THORACIC AORTIC DISSECTION AND
ANEURYSM
Although several population-based studies have re-
ported on the incidence of thoracic aortic diseases, their
true incidence is difﬁcult to ascertain.8,9 The debate remains
as to whether acute aortic dissection or ruptured AAA is the
most common form of aortic catastrophe.10-12 In a popula-
tion-based study over a 30-year review of the stableMidwest
area of Ohmsted county in the United States, Bickerstaff and
coauthors identiﬁed 296 persons with AAAs (196 men and
100 women) and reported an incidence of 21.1 per
100,000 person-years for the disease and an estimated
rupture incidence of 3.5 per 100,000 person-years.4 Bengts-
son and Bergqvist reported an incidence of 5.6 per 100,000
person-years for ruptured AAAs in a 16-year period (1971-
1986), in the city of Malmo in Sweden; 8.4/100,000 for
men and 3/100,000 women.5 Comparatively, a Hungarian
longitudinal population-based study over a 27-year period11S
Fig 1. A, Computed tomography (CT) angiogram of an acute
type A aortic dissection. Asterisk denotes the intimal ﬂap in the
aneurysmal ascending aorta. B, CT angiogram of an acute type B
aortic dissection. The intimal ﬂap is seen with partially thrombosed
false lumen in the descending thoracic aorta. A left pleural effusion
(*) is commonly seen in acute type B dissection even though the
aorta is not ruptured.
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years, and a male-to-female ratio of 1.55 to one.13 In a large
contemporary Swedish population study, 14,229 patients
were found to have thoracic aortic disease from 1987 to
2002 (including dissection and aneurysm of the thoracic
aorta); 62% were men and 38% women.9 The incidence of
thoracic aortic disease was 16.3 per 100,000 per year in
men and 9.1 % per 100,000 per year in women. In this study,
40% of patients had dissection, 40% had nonruptured aneu-
rysms, and 20% had aortic rupture. In the most recent report
on the population of Ohmsted County, Minn, the annual
age- and sex-adjusted incidence for acute aortic dissection
was 3.5 per 100,000 persons.11 Incidence rates increased
with age and the age-adjusted rates were 5.2 and 2.2 per
100,000 person-years for men and women, respectively.
Over a 15-year period (1980 -1994), the incidence of acute
aortic dissection rose from 2.7 to 4.1 per 100,000 person-
years, in the ﬁrst and last 5 years of the study period, respec-
tively, but this ﬁnding did not reach statistical signiﬁcance.
During the same period, a threefold increase in the incidence
of degenerative TAA to 10.4 per 100,000 person-years was
observed in the same region.14 The cumulative risk of TAA
rupture was 20% and the overall age- and sex-adjusted inci-
dence of rupture was 3.5 per 100,000 person-years; 79% of
ruptures occurred in women. All in all, the incidence of aortic
dissection reported in the literature is approximately 2 to 4
per 100,000 person-years and that of ruptured aortic aneu-
rysm is estimated at 5 to 10 per 100,000 person-years.
Hence, the older dogma that acute dissection is the most
common aortic catastrophe is probably no longer true.
RISK FACTORS
The International Registry of Acute Aortic Dissection
(IRAD) was formed in 1996 to overcome the small numbers
of patients in single-center studies with the aim to better
understand this relatively rare disease. Like all voluntary
registry data, ﬁndings derived from IRAD have inherent
bias. Nevertheless, we have learned invaluable facts regarding
the natural history and prognosis of patients with acute aortic
dissection from numerous publications written by the partic-
ipants of IRAD (Fig 1, A and B). In the ﬁrst 450 patients
enrolled in the registry (currently, there are over 2000
enrolled patients), acute type A aortic dissection is more
common than type B (1.65 : 1) and occurs in slightly
younger patients (mean age 61 vs 66, respectively).15,16
There is amale preponderance for both types of aortic dissec-
tion; 63% are men in type A dissection and 69% in type B.
Affected women are older than men. A later publication
from IRAD on 1078 patients showed that 50% of women
with aortic dissection were 70 years or older compared to
29% of affected men were in this age group.17 Hypertension
is the most common risk factor for acute aortic dissection
(69% for type A and 77% for type B).15,16
Degenerative aneurysm is generally detected in the 6th
and 7th decade of life, with women typically older than
men. Smoking history appears to be more prevalent in
patients with AAAs than in patients with TAAs. Aneurysm
size remains the best predictor for aortic rupture. Forpatients with a thoracic aneurysm smaller than 55 mm, the
risk of aortic rupture is 2% per year. The rupture rate
increases to greater than 7% per year for aneurysms 6 cm
or larger.14,18,19 Reports have shown that women have
a higher risk of TAA and AAA rupture than men.14,20 In
addition to smoking, patients with TAAs tend to have less
coronary artery disease, chronic lung disease, and diabetes
than do those with AAAs.21 The proportion of women
affected is also higher than AAA. The differences in risk
proﬁlemay reﬂect a different atherosclerotic proﬁle that plays
a role in the underlying mechanism of action of TAA
development.
A review of 11,166 patients from the Medicare database
(2004-2007) who underwent descending thoracic aortic
(DTA) repair revealed no gender differences for aneurysm
rupture, traumatic disruption, or dissection.22 A higher
percentage of men, however, had DTA repair for intact
aneurysms by endovascular means than did women. This is
a trend reﬂected in infrarenal AAA repairs as well. The reason
remains elusive.
FAMILIAL AND GENETIC FACTORS
Marfan syndrome is a heritable autosomal dominant
disorder linked to a mutation in the human ﬁbrillin-1 gene
Fig 2. Takayasu arteritis. Magnetic resonance angiogram image of
a 57-year-old woman with Takayasu arteritis showing stenosis of
the descending thoracic and abdominal aorta and an intervening
aneurysmal segment of the distal descending thoracic aorta.
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aortic aneurysm and dissection. Estimates indicate that one
in 5000 people haveMarfan syndrome, andmen andwomen
are affected equally. Marfan patients are known to be at risk
for aortic dissection and aneurysm formation at a younger
age, but only 5% of patients in IRAD had Marfan syndrome
(7% had type A and 2% had type B).15,16 Reassuring ﬁndings
from IRAD also included no increased risk for aortic dissec-
tion in pregnant femaleMarfan syndrome patients and a rela-
tively low overall incidence of aortic dissection during
pregnancy (only two patients of 346 women in IRAD).17
Interestingly, the prevalence of bicuspid valves was greater
in Marfan syndrome women with dissection than in Marfan
syndrome men with dissection. Ehlers-Danlos syndrome
type IV is a rare disorder that results from mutations in the
gene for type III procollagen and affects women and men
equally.23 Surgical repair of involved vessels in Ehlers-Danlos
syndrome patients is technically challenging because of the
tissue friability and has been reserved for vessel rupture,
limb ischemia, or impending complications. Endovascular
treatment has been reported as a safe alternative approach
for patients diagnosed with vascular complications of
Ehlers-Danlos syndrome.24
THORACIC AORTIC DISEASES THAT ARE
MORE PREVALENT IN WOMEN
Turner syndrome occurs in one out of every 2000 to
3000 live female births.25 The syndrome is due to partial
or complete loss of a second X chromosome. Fifty percent
of affected patients have congenital cardiovascular defects,
namely, bicuspid aortic valve and coarctation of the aorta,
and are at increased risk for progressive aortic root dilatation,
aneurysm, and dissection of the ascending aorta.26 The
current recommendation is for all women with Turner
syndrome to undergo a complete echocardiographic evalua-
tion and a cardiac and aortic magnetic resonance angiogram
imaging every 5 years. Further study is needed to determine
the role of b-blockade and renin-angiotensin system
blockade in the prevention of aortic dilatation and whether
prophylactic surgical aortic graft replacement will reduce
the incidence of aortic dissection and rupture.
Takayasu arteritis is a rare inﬂammatory disorder of the
aorta or the arch branch vessels, with a predilection for young
Asianwomen (Fig 2). The average age at diagnosis is 25 to 30
years, and 80% to 90% of affected persons are women. The
exact cause of this disorder is still unknown, but studies
have suggested an underlying cell-mediated autoimmune
pathophysiology. The diagnosis of Takayasu arteritis is
made based on the clinical presentation, imaging, and labora-
tory tests (markers of acute inﬂammation, C-reactive protein,
and erythrocyte sedimentation rate, in the acute phase). The
abdominal aorta is the most common site of involvement fol-
lowed by the descending thoracic aorta. Takayasu arteritis
commonly leads to stenosis of the aorta or the great vessels
(innominate, common carotid, and subclavian arteries) and
aortic aneurysm formation.27Once the diagnosis of Takayasu
arteritis is made, oral glucocorticoid should be initiated.
In general, patients should be in clinical remission before“elective” repair for aortic aneurysm or occlusive disease is
considered. Endovascular intervention has become the ﬁrst
option for patients with Takayasu arteritis-related complica-
tions, and surgical bypass grafting is usually reserved for
patients who either fail endovascular treatment or in whom
this is not possible.
MANAGEMENT OF ACUTE AORTIC DISSEC-
TION (ACUTE AORTIC SYNDROMES)
It is estimated that without proper treatment, only 10%
of patients with type A aortic dissection and 40% with type
B (DTA dissection or distal) will be alive at 1 year. The stan-
dard management for type A aortic dissection remains
surgical repair and that for type B is still medical anti-
impulse therapy. The in-hospital mortality rate for patients
with acute type A aortic dissection in IRAD receiving surgery
was 26.6% and 55.9% for those treated with medical therapy
alone.16 Predictors of in-hospital mortality were age >70
years, abrupt onset of chest pain, presence of hypotension/
shock/tamponade, and abnormal EKG readings. Female
gender is predictive of adverse events for acute aortic
syndromes and higher in-hospital mortality rates.17 Several
clinical characteristics were found to be different in women
compared with men with regard to their presentation.
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symptoms. Women were less likely to present with abrupt
onset of chest pain. Congestive heart failure and coma/
altered mental status were more common presentation in
women. Similarly, worrisome imaging ﬁndings of coronary
artery compromise, pleural effusion, periaortic hematoma,
and pericardial effusion were more common in women.
Although no signiﬁcant differences were found in the
surgical techniques used for women and men, outcomes
were worse in women compared with men, with operative
mortality of 32% vs 22%, respectively. Similarly, in-hospital
complications of hypotension and tamponade were seen
more in women than men.
Since the introduction of the rapidly advancing endovas-
cular technology, catheter-based aortic intervention for type
B aortic complications is promising, but more studies are
needed to determine its role. Forty-six patients in IRAD
had endovascular treatment for type B aortic dissection
with a 6.5% mortality rate.16 There was no gender difference
in the in-hospitality mortality rate for acute type B aortic
dissection. However, female gender was predictive for
long-term death in patients with chronic type B dissection.
According to IRAD, one in four acute type B dissection
survivors will die at 3-year follow-up.28 The reported unad-
justed survival rate for patients with chronic type B dissection
from IRAD was reported to be 90% and 77% at 1- and
3-years, respectively, after discharge following the acute
episode. Predictors of late mortality include in-hospital
hypotension and renal failure and history of prior aortic
aneurysm and arteriosclerosis.
The natural histories of acute intramural hematoma
(IMH) and penetrating aortic ulcer (PAU) continue to be
debated. It is estimated that acute IMH accounts for 5% to
20% of patients presenting with acute aortic syndromes.16
The current treatment for IMH patients parallels that for
classic aortic dissection. It has been suggested that PAU
may be more malignant than the classic type B aortic dissec-
tion and associated with higher risk of rupture.29,30 Success-
ful endovascular repair of the descending thoracic aorta has
been reported for patients with complicated PAU.30 The
reported gender ratio for IMH and PAU is approximately
3:2 in favor of men.OPEN SURGICAL REPAIR FOR DESCENDING
THORACIC AND THORACOABDOMINAL
AORTIC ANEURYSMS AND OUTCOME
Reported outcomes for open surgical repair of DTA and
thoracoabdominal aortic (TAA) aneurysms from high-
volume institutions in the United States and Europe have
continued to improve, but mortality and complication rates
remain relatively high compared with other cardiovascular
interventions. Spinal cord ischemia and renal failure are the
two most devastating complications after open surgery for
DTA and TAA aneurysms, both of which are associated
with increased mortality. The mortality rate for open surgical
repair of intact and ruptured DTAs was approximately 10%
and 45%, respectively, published in a study based on theInpatient Sample Database in the United States from 1988
to 2003.31 In a series of 300 patients undergoing open
surgical repair for DTAs, 34% were women and 38% had
chronic dissection.32 In this series, the in-hospital mortality
was 8% and 5-yearmortality was 64%, with incidence of spinal
cord ischemia of 2.3% and renal failure of 4.2%. Independent
predictors for early mortality were female gender
and preoperative renal insufﬁciency. In an abstract presented
at the American Heart Association Annual Meeting in 2004
(unpublished data), Saﬁ et al showed that female gender
was not a signiﬁcant risk factor for death or complications in
their overall experience with 1004 patients with TAAs and
DTA aneurysm open repair. Interestingly, women had less
chronic dissection compared with men (15.0% vs 31.6%),
less coronary artery disease history (20.9% vs 30.1%), less
history of coronary artery bypass graft (10.2% vs 18.1%),
and less history of AAA repair (6.4% vs 17.8%). In contrast,
women were more likely to report current smoking (38.1%
vs 27.9%), and more women reported a history of chronic
obstructive pulmonary disease (36.2% vs 30.1%).
Although these reports are helpful to predict early
surgical outcome in women, data is sparse on late outcome
of DTA and TAA repair in men and women. A Massachu-
setts General report of 333 patients undergoing DTA repair
over a 15-year period showed a 10% rate of late aortic events
(another elective aneurysm repair, embolization, urgent/
emergent aneurysm operation, acute dissection) at an
average of 30 months after original surgery.33 Female
gender, presentation with rupture, and unresected disease
were independently associated with a higher risk of late event
occurrence. Since a signiﬁcant proportion of DTA aneurysm
repairs are performed in women, there may be a need for
improving/modifying postoperative surveillance in this
group to prevent late aortic events. Certainly, further inves-
tigation is warranted.
Functional outcomes after TAA repair are seldom
studied, especially in regard to gender differences. Female
gender (age corrected) and age greater than 75 years have
been found to correlate with decreased physical functioning
after TAA repair in a study utilizing the Short-Form 36-
Item Health Survey tool.34 Permanent loss of function at
5 years, however, was rare. Quality-of-life measures have
becomeevenmore important in this diseaseprocessover stan-
dard AAA, as almost 50% of TAA repairs are performed in
women. It is encouraging to note that the initial decrease in
functional capacity is not long-lived.
THORACIC ENDOVASCULAR AORTIC ANEU-
RYSM REPAIR AND OUTCOME
Women have been found to undergo endovascular
infrarenal AAA repair (EVAR) less frequently than men.
A review of 93 patients considered for thoracic endovascu-
lar Aortic Aneurysm repair (TEVAR) found 26% of patients
were unsuitable for the endovascular approach due to
anatomic reasons.35 This was most commonly due to an
unfavorable proximal neck, but there was no gender differ-
ence elucidated. Women did have a tendency toward
having more difﬁcult arterial anatomy for access than
Fig 3. Blunt traumatic transection of the proximal descending thoracic aorta. A, Axial computed tomography (CT)
angiogram image shows the transection in the proximal descending thoracic aorta (arrow points to injury), and the
asterisk denotes a periaortic hematoma. B, Reformatted sagittal CT angiogram image demonstrates the injury (*) in the
proximal descending thoracic aorta just distal to the left subclavian artery. C, Intraoperative photograph shows the
injured thoracic aorta (with periaortic hematoma (*) intact). D, Intraoperative photograph of the completed graft
repair of the descending thoracic aorta. E, Digital substraction image of a completed endograft repair of a transected
proximal descending thoracic aorta with coverage of the left subclavian artery (“bovine” arch with patent common
origin of the innominate and left common carotid arteries) in a different patient.
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raft technology, more women can undergo both EVAR
and TEVAR more safely.
Demographically, in a recent review of the TAG stent
graft trials at 1 year, women were found to be less likely to
have had a prior vascular procedure and to trend towardhaving less coronary artery disease and smoking history
than men.36 They also tended to be nonwhite. There was
a 24.4% conduit rate in women, vs 6% in men, reinforcing
the concept of smaller, potentially more diseased access
vessels. There was no difference between the genders in
successful device delivery or endoleak rate.
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multicenter trials showed remarkably similar results for
thoracic endovascular repair of DTA aneurysms.37-40 The
30-day mortality rate ranged from 1.5% to 2.1%. The most
commonTEVAR complication was related to femoral artery
access (up to 22% of cases), likely in part, because of the large
proﬁle of the delivery system ($20F); themore liberal use of
iliac conduit subsequently reduced the occurrence of this
complication. Other complications were stroke (2.5%-
3.6%) and paraplegia/paraparesis (2.8%-8.7%). Women
were well represented in all these trials in proportion to
the natural incidence (about 30%). Female gender did not
appear to be predictive for mortality or complications,
except in a database review of the Gore Pivotal Trial.41
Women had a longer procedure time for both endovascular
and open approaches, which correlated with increased
complications in the endovascular group. Despite this
ﬁnding, male gender was more predictive of death overall.
Even with more complicated repairs involving hybrid proce-
dures involving TAA endovascular repair combined with
visceral and renal bypasses, there were no differences in
outcome between the genders.42
Typically, there are more men than women involved in
trauma; most series report about 20% to 30% of patients
with traumatic transection of the thoracic aorta are female.
The traditional approach of open repair is being challenged
in the era of emerging endovascular techniques (Fig 3,A-E).
Risk of paraplegia is very low after TEVAR for trauma,
approaching 0% to 1%, compared with up to 10% in histor-
ical series of open surgical repair.43-45 In these younger
patients, it is particularly important to keep in mind that
the current endografts were designed to have a durability
of 10 years based on the International Standardization
Organization stress testing and their long-term durability
is unknown. In addition, thoracic endografts were not
initially designed to ﬁt the tight radius of curvature that
younger patients possess, nor the smaller diameters in
women and younger patients. The endograft industry will
likely continue to improve their design and produce better
devices to ﬁt the different aortic morphology and pathology.
In summary, we provided an up-to-date review of the
epidemiology and management of common diseases of
the thoracic aorta, focusing on the differences and similar-
ities in women and men. Although thoracic aortic diseases
remain more common in men, reports show that both
women and men have comparable treatment outcomes.
As the endovascular technology continues to evolve, we
look forward to lasting improvements in the treatment of
thoracic aortic diseases for patients of both genders.AUTHOR CONTRIBUTIONS
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